Development and evaluation of a preliminary risk assessment model for psychological distress among patients with brain tumors: a cross-sectional analysis - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Development and evaluation of a preliminary risk assessment model for psychological distress among patients with brain tumors: a cross-sectional analysis
Clinical Scorecard: Development and evaluation of a preliminary risk assessment model for psychological distress among patients with brain tumors: a cross-sectional analysis
At a Glance
Category
Detail
Condition
Psychological distress in brain tumor patients
Key Mechanisms
Financial toxicity, self-efficacy, medical coping strategies
Target Population
Patients with histopathologically confirmed brain tumors aged 18-80
Care Setting
Neuro-oncology Department, Sun Yat-sen University Cancer Center
Key Highlights
44.5% to 76.0% of brain tumor patients experience clinically significant psychological distress.
Financial toxicity significantly correlates with psychological distress.
Self-efficacy inversely relates to psychological distress.
Adaptive coping strategies can mitigate psychological distress.
Early screening for psychological distress is crucial for intervention.
Guideline-Based Recommendations
Diagnosis
Implement early screening for psychological distress in brain tumor patients.
Management
Develop targeted psychosocial care programs based on identified risk factors.
Monitoring & Follow-up
Regularly assess psychological distress and self-efficacy in patients.
Risks
Consider financial toxicity as a significant risk factor for psychological distress.
Patient & Prescribing Data
321 brain tumor patients recruited from a single center.
Financial strain and low self-efficacy are critical factors influencing psychological distress.
Clinical Best Practices
Utilize adaptive coping strategies to enhance patient quality of life.
Encourage patient participation in medical decision-making to improve self-efficacy.
Address financial toxicity in treatment planning and support.